U.S. Advisory Panel to Discuss Paused Johnson & Johnson Vaccine
A U.S. advisory panel was set to meet Friday to discuss the Johnson & Johnson COVID-19 vaccine that was paused when six women suffered blood clots after receiving the shot. A seventh case is now being investigated. Kris Sanchez reports.